Sonendo slid over 20% in morning trading,below its IPO price at 12 dollars per share.It is a commercial-stage medical technology company focused on dental care.In the first half of 2021, Sonendo (SONX) recorded $8.5M in total revenue, indicating 44.6% YoY decline while net loss expanded 6.8% YoY to $23.5M.